Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/136295
Full metadata record
DC FieldValueLanguage
dc.creatorMeira, L
dc.creatorChaves, C
dc.creatorAraújo, D
dc.creatorAlmeida, L
dc.creatorBoaventura, R
dc.creatorRamos, A
dc.creatorCarvalho, T
dc.creatorOsório, NS
dc.creatorCastro, AG
dc.creatorRodrigues, F
dc.creatorGuimarães, JT
dc.creatorSaraiva, M
dc.creatorBastos, HN
dc.date.accessioned2021-09-20T10:52:48Z-
dc.date.available2021-09-20T10:52:48Z-
dc.date.issued2019
dc.identifier.issn2531-0429
dc.identifier.urihttps://hdl.handle.net/10216/136295-
dc.description.abstractSetting: University-affiliated hospital located in Porto, North Portugal, an area with a low to intermediate incidence of tuberculosis (TB). Objective: To identify predictors and outcomes of disseminated TB (dTB). Design: A cohort of patients diagnosed with TB between 2007 and 2013 was retrospectively analysed. Patients with dTB criteria were characterized and compared to single organ TB cases. Factors independently associated with dTB were determined by multivariate logistic regression analysis. Results: A total of 744 patients were analysed, including 145 with dTB. Independent risk factors for dTB were pharmacological immunosuppression (OR 5.6, 95% CI 2.8–11.3), HIV infection (OR 5.1, 95% CI 3.1–8.3), chronic liver failure or cirrhosis (OR 2.3, 95% CI 1.4–4.1) and duration of symptoms (OR 2.3, 95% CI 1.4–3.8). Compared to single organ TB, the clinical presentation of dTB patients differed by the absence of haemoptysis (OR 3.2, 95% CI 1.3–8.4) and of dyspnoea (OR 1.9, 95% CI 1.2–3.1), presence of weight loss (OR 1.8, 95% CI 1.1–2.9), night sweats (OR 1.7, 95% CI 1.1–2.7) and bilateral lung involvement (OR 4.4, 95% CI 2.8–7.1). Mortality and time until culture conversion were higher for dTB patients, although not reaching statistical significance. Conclusion: Immunosuppressive conditions and chronic liver failure or cirrhosis were associated with increased risk of dTB. The haematogenous spread may be dependent on longer symptomatic disease and usually progresses with bilateral lung involvement.
dc.description.sponsorshipWe acknowledge the support of Dr. Ana Maria Correia, Dr. Eduardo Coutinho and Olga Barbosa in providing us access to the regional TB surveillance system data. HNB acknowledges the receipt of research scholarships from Bolsa D. Manuel de Mello and the Portuguese Society for Pneumology . NSO acknowledges FCT IF/00474/2014. The MS lab is financed by FEDER – Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 – Operational Programme for Competitiveness and Internationalisation (POCI), Portugal 2020, and by Portuguese funds through FCT in the framework of the project “Institute for Research and Innovation in Health Sciences” (POCI-01-0145-FEDER-007274). MS and NSO are FCT Associate Investigators. The funding agencies had no role in the design of the manuscript.
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofPulmonology, vol.25(6), p. 320-327
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAntitubercular Agents / therapeutic use
dc.subject.meshChi-Square Distribution
dc.subject.meshFemale
dc.subject.meshHIV Infections / complications
dc.subject.meshHumans
dc.subject.meshImmunocompromised Host
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshMycobacterium tuberculosis / isolation & purification
dc.subject.meshOdds Ratio
dc.subject.meshPortugal / epidemiology
dc.subject.meshRegression Analysis
dc.subject.meshRetrospective Studies
dc.subject.meshRisk Factors
dc.subject.meshSmoking / epidemiology
dc.subject.meshStatistics, Nonparametric
dc.subject.meshTuberculosis, Miliary / diagnosis
dc.subject.meshTuberculosis, Miliary / drug therapy
dc.subject.meshTuberculosis, Miliary / epidemiology
dc.subject.meshTuberculosis, Miliary / etiology
dc.titlePredictors and outcomes of disseminated tuberculosis in an intermediate burden setting
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.1016/j.pulmoe.2018.11.001
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S2531043718301788?via%3Dihub
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.1016-j.pulmoe.2018.11.001.pdf438.31 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons